Integrated BioPharma, Inc. (INBP)
OTCMKTS · Delayed Price · Currency is USD
0.2770
-0.0030 (-1.07%)
Oct 3, 2025, 3:39 PM EDT

Integrated BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Oct '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
9116101533
Upgrade
Market Cap Growth
14.33%75.42%-36.28%-33.74%-54.33%146.41%
Upgrade
Enterprise Value
696101941
Upgrade
Last Close Price
0.280.360.210.330.501.10
Upgrade
PE Ratio
10.3913.7256.44-3.904.09
Upgrade
PS Ratio
0.160.200.130.200.270.52
Upgrade
PB Ratio
0.420.550.330.530.812.29
Upgrade
P/TBV Ratio
0.420.550.330.530.812.29
Upgrade
P/FCF Ratio
4.595.9216.218.894.1511.90
Upgrade
P/OCF Ratio
4.175.376.708.053.6610.75
Upgrade
EV/Sales Ratio
0.110.170.130.200.350.64
Upgrade
EV/EBITDA Ratio
1.793.9611.3621.856.316.68
Upgrade
EV/EBIT Ratio
2.974.5925.2685.757.087.07
Upgrade
EV/FCF Ratio
3.204.9416.269.225.3914.84
Upgrade
Debt / Equity Ratio
0.050.050.090.140.110.42
Upgrade
Debt / EBITDA Ratio
0.300.301.151.910.550.84
Upgrade
Debt / FCF Ratio
0.540.544.612.390.572.18
Upgrade
Asset Turnover
2.132.131.952.002.222.63
Upgrade
Inventory Turnover
4.744.744.324.374.374.96
Upgrade
Quick Ratio
2.132.131.041.210.990.66
Upgrade
Current Ratio
4.424.422.923.393.161.95
Upgrade
Return on Equity (ROE)
4.08%4.08%0.59%-0.18%23.33%78.55%
Upgrade
Return on Assets (ROA)
4.94%4.94%0.61%0.30%6.77%14.94%
Upgrade
Return on Capital (ROIC)
5.96%5.96%0.74%0.36%8.38%19.26%
Upgrade
Return on Capital Employed (ROCE)
9.80%9.80%1.20%0.60%13.70%35.70%
Upgrade
Earnings Yield
9.39%7.29%1.77%-0.34%25.64%24.44%
Upgrade
FCF Yield
21.78%16.90%6.17%11.25%24.08%8.40%
Upgrade
Buyback Yield / Dilution
-0.95%-0.95%-3.08%7.34%-0.65%-3.07%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.